aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in 2015, Alto Pharmacy is a leading digital pharmacy in the United States, aiming to transform the $500 billion pharmacy industry. The company's core mission is to enhance the role of pharmacists in healthcare by leveraging technology to provide a more convenient and affordable medication management experience. Alto offers services such as prescription fulfillment, medication delivery, and a mobile app for seamless management. The company focuses on improving patient outcomes and accessibility in the pharmaceutical market.
Notable affiliated individuals include co-founders Jamie Karraker and Matt Gamache-Asselin. Alto has attracted significant investment from prominent venture capital firms like SoftBank Vision Fund and Greenoaks Capital. Key achievements include fulfilling over three million prescriptions and expanding operations to twelve markets. Alto's innovative approach has significantly impacted the digital pharmacy landscape, making medication management more efficient and patient-centric.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Medication Management, Pharmacy
Technology
Telemedicine
Tags
Healthtech
Model Types
SaaS, Platform
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Consumers
Geographic Exposure
United States
When was Alto Pharmacy founded?
Alto Pharmacy was founded in 2015.
Where is Alto Pharmacy's headquarters located?
Alto Pharmacy's headquarters is located in Los Angeles, CA, US.
When was Alto Pharmacy's last funding round?
Alto Pharmacy's most recent funding round was for $120M (USD) in September 2023.
How many employees does Alto Pharmacy have?
Alto Pharmacy has 994 employees as of Feb 4, 2024.
How much has Alto Pharmacy raised to-date?
As of July 05, 2023, Alto Pharmacy has raised a total of $680M (USD) since Sep 25, 2023.
Add Comparison
Total Raised to Date
$680M
USD
Last Update Sep 25, 2023
Last Deal Details
$120M
USD
Sep 25, 2023
Series F
Total Employees Over Time
994
As of Feb 2024
Alto Pharmacy Address
Los Angeles,
California
90071
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts